Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity

Melissa Richard-Greenblatt, Matthew J. Ziegler, Valerie Bromberg, Elizabeth Huang, View ORCID ProfileHatem Abdallah, Pam Tolomeo, Ebbing Lautenbach, Laurel Glaser, View ORCID ProfileBrendan J. Kelly
doi: https://doi.org/10.1101/2020.12.09.20246520
Melissa Richard-Greenblatt
1Department of Pathology and Laboratory Medicine; University of Pennsylvania, Philadelphia, PA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. Ziegler
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Bromberg
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Huang
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hatem Abdallah
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hatem Abdallah
Pam Tolomeo
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebbing Lautenbach
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
MD, MPH, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurel Glaser
1Department of Pathology and Laboratory Medicine; University of Pennsylvania, Philadelphia, PA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan J. Kelly
2Division of Infectious Diseases, Department of Medicine; University of Pennsylvania, Philadelphia, PA
3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brendan J. Kelly
  • For correspondence: brendank{at}pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) cycle of threshold (Ct) has been used to estimate quantitative viral load, with the goal of targeting isolation precautions for individuals with COVID-19 and guiding public health interventions. However, variability in specimen quality can alter the Ct values obtained from SARS-CoV-2 clinical assays. We sought to define how variable nasopharyngeal (NP) swab quality impacts clinical SARS-CoV-2 test sensitivity.

Methods We performed amplification of a human gene target (β-actin) in parallel with a clinical RT-PCR targeting the SARS-CoV-2 ORF1ab gene for 1311 NP specimens collected from patients with clinical concern for COVID-19. We evaluated the relationship between NP specimen quality, characterized by high Ct values for the human gene target β-actin Ct, and the probability of SARS-CoV-2 detection via logistic regression, as well as the linear relationship between SARS-CoV-2 and β-actin Ct.

Results Low quality NP swabs are less likely to detect SARS-CoV-2 (odds ratio 0.654, 95%CI 0.523 to 0.802). We observed a positive linear relationship between SARS-CoV-2 and β-actin Ct values (slope 0.169, 95%CI 0.092 to 0.247). COVID-19 disease severity was not associated with β-actin Ct values.

Conclusions Variability in NP specimen quality accounts for significant differences in the sensitivity of clinical SARS-CoV-2 assays. If unrecognized, low quality NP specimens, which are characterized by a low level of amplifiable human DNA target, may limit the application of SARS-CoV-2 Ct values to direct infection control and public health interventions.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NA

Funding Statement

BJK, MJZ, and EL are supported in part by a CDC Cooperative Agreement FOA#CK16-004 "Epicenters for the Prevention of Healthcare Associated Infections". BJK is supported by the National Institute for Allergy and Infectious Diseases (K23 AI121485 and L30 AI120149). MJZ is supported by the National Institute for Allergy and Infectious Diseases (K23 AI143925).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

A waiver of informed consent was granted by the University of Pennsylvania Institutional Review Board (IRB protocols #843085 & #843274).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data, analysis scripts, and model code are available at https://github.com/bjklab/Impact-of-NP-Specimen-Quality-on-SARS-CoV-2-Test-Performance

https://github.com/bjklab/Impact-of-NP-Specimen-Quality-on-SARS-CoV-2-Test-Performance

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity
Melissa Richard-Greenblatt, Matthew J. Ziegler, Valerie Bromberg, Elizabeth Huang, Hatem Abdallah, Pam Tolomeo, Ebbing Lautenbach, Laurel Glaser, Brendan J. Kelly
medRxiv 2020.12.09.20246520; doi: https://doi.org/10.1101/2020.12.09.20246520
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity
Melissa Richard-Greenblatt, Matthew J. Ziegler, Valerie Bromberg, Elizabeth Huang, Hatem Abdallah, Pam Tolomeo, Ebbing Lautenbach, Laurel Glaser, Brendan J. Kelly
medRxiv 2020.12.09.20246520; doi: https://doi.org/10.1101/2020.12.09.20246520

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3288)
  • Dentistry and Oral Medicine (364)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13358)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5147)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14622)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4919)
  • Nursing (262)
  • Nutrition (727)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2519)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4205)
  • Public and Global Health (7499)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1011)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)